FDA Approval of New Therapy, Duvyzat, for Duchenne Muscular Dystrophy Represents Several Meaningful Firsts By Charles G. Raver & James E. Valentine & Frank J. Sasinowski —

https://www.thefdalawblog.com/2024/03/fda-approval-of-new-therapy-duvyzat-for-duchenne-muscular-dystrophy-represents-several-meaningful-firsts/?utm_source=rss&utm_medium=rss&utm_campaign=fda-approval-of-new-therapy-duvyzat-for-duchenne-muscular-dystrophy-represents-several-meaningful-firsts